Di Pietro M C, Vannoni D, Leoncini R, Liso G, Guerranti R, Marinello E
Institute of Biochemistry and Enzymology, University of Siena, Italy.
J Chromatogr B Biomed Sci Appl. 2001 Feb 10;751(1):87-92. doi: 10.1016/s0378-4347(00)00471-0.
We describe the group selective separation and quantification of unmodified and modified purines in human urine by high-performance reverse phase liquid chromatography. The pattern of oxypurines and methylated purines: hypoxanthine (Hx), xanthine (X), 1-methyl hypoxanthine (1-MHx), 1-methyl guanine (1-MG), 3-methyl guanine (3-MG), 7-methyl guanine (7-MG), 1-methyl xanthine (1-MX), 3-methyl xanthine (3-MX), 7-methyl xanthine (7-MX), 1,7-dimethyl guanine (1,7-dMG), 1,3-dimethyl xanthine (1,3-dMX), 1,7-dimethyl xanthine (3,7-dMX) and 1,3,7-trimethyl xanthine (1,3,7-tMX) were determined in a single run in urine of a healthy subject and a gout patient before and after treatment with allopurinol. This method may be useful to investigate the urinary pattern of methylated bases in diseases involving purine metabolism.
我们描述了通过高效反相液相色谱法对人尿中未修饰和修饰嘌呤进行组选择性分离和定量的方法。在健康受试者和痛风患者服用别嘌醇治疗前后的尿液中,单次测定了氧嘌呤和甲基化嘌呤的模式:次黄嘌呤(Hx)、黄嘌呤(X)、1-甲基次黄嘌呤(1-MHx)、1-甲基鸟嘌呤(1-MG)、3-甲基鸟嘌呤(3-MG)、7-甲基鸟嘌呤(7-MG)、1-甲基黄嘌呤(1-MX)、3-甲基黄嘌呤(3-MX)、7-甲基黄嘌呤(7-MX)、1,7-二甲基鸟嘌呤(1,7-dMG)、1,3-二甲基黄嘌呤(1,3-dMX)、1,7-二甲基黄嘌呤(3,7-dMX)和1,3,7-三甲基黄嘌呤(1,3,7-tMX)。该方法可能有助于研究涉及嘌呤代谢的疾病中甲基化碱基的尿模式。